FDA DrugClass IINotable
FDA Recall: Alyacen 7/7/7, Norethindrone and Ethinyl Estradiol Tablets USP, 0.5mg/0.035mg, 0.75mg/0.035mg, 1 mg/
Description
Failed Impurities/Degradation Specifications: This recall is being initiated due to out-of-specification results total impurities.
Hazard
Failed Impurities/Degradation Specifications: This recall is being initiated due to out-of-specification results total impurities.
Related Recalls
2026-08-12 · FDA_DRUG
FDA Recall: Mirabegron Extended-Release Tablets, 25 mg, 30-count bottle, Rx only, Manufactured by: Zydus Lifesci
Zydus Pharmaceuticals (USA) Inc
2026-08-12 · FDA_DRUG
FDA Recall: Dicyclomine Hydrochloride Capsules, USP, 10mg, 1,000 bottles, Rx only, Distributed by: Aurobindo Pha
Aurobindo Pharma USA Inc
2026-08-12 · FDA_DRUG
FDA Recall: Cyclophosphamide for Injection, USP, 2 gram/vial, One Single-Dose Vial, Rx only, Manufactured for: L
Sunny Pharmtech Inc.
2026-08-12 · FDA_DRUG
FDA Recall: Cyclophosphamide for Injection, USP, 1 gram/vial, One Single-Dose Vial, Rx only, Manufactured for: L
Sunny Pharmtech Inc.